ResearcherNanjing General Hospital of Nanjing Military CommandActive in the last 2 years
Yonghao Ouyang
Matched on ORCID iD 0000-0002-7075-9173; OpenAlex author ID A5091947751. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2023: 1 paper · 2024: 3 papers · 2025: 1 paper
Papers 5
- IND-Enabling Studies for a TCR-T Targeting a Pancreatic Cancer KRASG12V Mutation. Co-author DOI 10.1158/1078-0432.ccr-24-3086↗
- Causal associations of tea consumption on risk of pancreatic adenocarcinoma and the mediating role of vascular endothelial growth factor D levels. Co-author DOI 10.1017/s0007114524002393↗
- Causal associations of tea consumption on risk of pancreatic adenocarcinoma and the mediating role of vascular endothelial growth factor D levels - CORRIGENDUM. Co-author DOI 10.1017/s0007114524003155↗
- Combining single-cell and bulk RNA sequencing, NK cell marker genes reveal a prognostic and immune status in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41598-024-65917-1↗
- Establishment of a novel signature to predict prognosis and immune characteristics of pancreatic cancer based on necroptosis-related long non-coding RNA. Co-author DOI 10.1007/s11033-023-08663-3↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xin Chen · 3 shared papers, 2024 · strength 0.73
- Paper Causal associations of tea consumption on risk of pancreatic adenocarcinoma and the mediating role of vascular endothel… DOI 10.1017/s0007114524002393↗
- Paper Causal associations of tea consumption on risk of pancreatic adenocarcinoma and the mediating role of vascular endothel… DOI 10.1017/s0007114524003155↗
- Paper Combining single-cell and bulk RNA sequencing, NK cell marker genes reveal a prognostic and immune status in pancreatic… DOI 10.1038/s41598-024-65917-1↗
- Rongxi Shen · 2 shared papers, 2024–2025 · strength 0.41
- Jiajia Lei · 1 shared paper, 2024 · strength 0.26
- Jiajia Lei · 1 shared paper, 2024 · strength 0.26
- Xinbo Wang · 1 shared paper, 2025 · strength 0.19
- Hong‐Ming Hu · 1 shared paper, 2025 · strength 0.19
- Sizhen Wang · 1 shared paper, 2025 · strength 0.19
- Yimin Chen · 1 shared paper, 2025 · strength 0.19
- Gen Sun · 1 shared paper, 2023 · strength 0.18
- Weidong Xiao · 1 shared paper, 2023 · strength 0.18
- Yuanpeng Xiong · 1 shared paper, 2023 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.